Task: Answer the multiple-choice question.
Query: Which drug exhibits a 2.082% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] Cc1cc(C)n(CC(=O)N2CCCC(N3CCN(Cc4ccc5c(c4)OCO5)CC3)C2)n1
[b] COc1cccc(NC(=O)CN(C)C(=O)/C=C/c2cn(Cc3ccccc3)nc2-c2cccnc2)c1
[c] O=C(CSc1ccccc1C(=O)O)NCc1ccccc1
Answer: c. O=C(CSc1ccccc1C(=O)O)NCc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1ccccc1C(=O)O)NCc1ccccc1
O=C(CSc1ccccc1C(=O)O)NCc1ccccc1
2-[2-(benzylamino)-2-oxoethyl]sulfanylbenzoic acid